Mega Batin Capsules 300 mg
Mega Batin Capsules 300 mg
Pharmaceutical
| Ingredients and content | Gabapentin 300mg |
| Efficacy · effect |
1. Epilepsy 1) Monotherapy (including treatment for patients newly diagnosed with seizures): simple/complex partial seizures with or without secondary systemic symptoms in adolescents or adults over 13 years of age 2) Additive therapy: Partial seizures with or without secondary systemic symptoms in children over 3 years of age or adults 2. Neuropathic pain |
| Usage · Dosage |
1. Epilepsy 1) Monotherapy and adjunctive therapy for patients 13 years of age or older Step-wise titration is performed over the first 3 days of dosing as follows to achieve a maintenance dose of 900 mg/day as gabapentin. 2) Additive therapy for children aged 3 to 12 years Stepwise titration to a maintenance dose of 30 mg/kg body weight as gabapentin is performed over the first 3 days of administration as follows. 2. Neuropathic pain Adults (18 years and older): Step-by-step titration to a maintenance dose of 900 mg/day as gabapentin is performed over the first 3 days of administration as follows. 3. the weak : In patients with low body weight or after transplantation, the gabapentin dose should be increased in 100 mg increments. 4. Elderly : Dose adjustment may be necessary due to deterioration of renal function due to old age (see table). 5. Patients with renal dysfunction (creatinine clearance less than 80 mL/min) or patients undergoing hemodialysis : Dose adjustment is necessary based on the following table. |
| Period of use and storage method | 36 months from MFD, Airtight container, room temperature (1∼30℃) |
| Packaging information |
30 capsules/bottle, 100 capsules/bottle |
